BRIEF published on 03/20/2026 at 15:49, 17 days 20 hours ago Guerbet: Publication of the 2025 Universal Registration Document Financial Report Guerbet Medical Imaging Financial Markets Registration Document
BRIEF published on 03/20/2026 at 15:49, 17 days 20 hours ago Guerbet : Publication du Document d'enregistrement universel 2025 Rapport Financier Guerbet Imagerie Médicale Marchés Financiers Document D'enregistrement
PRESS RELEASE published on 03/20/2026 at 15:44, 17 days 20 hours ago GUERBET : Mise à disposition du Document d’enregistrement universel 2025 Guerbet dépose son Document d’enregistrement universel 2025 à l'AMF. Consultation gratuite en ligne. Prochain RDV : Publication du chiffre d’affaires du 1er trimestre 2026 le 23 avril 2026 Chiffre D’affaires AMF Guerbet Publication Document D’Enregistrement Universel 2025
BRIEF published on 02/20/2026 at 17:50, 1 month 14 days ago Guerbet: Capital update as of January 31, 2026 Voting Rights Capital Actions Guerbet 2026
BRIEF published on 02/20/2026 at 17:50, 1 month 14 days ago Guerbet : Mise à jour sur le capital au 31 janvier 2026 Capital Droits De Vote Actions Guerbet 2026
PRESS RELEASE published on 02/20/2026 at 17:45, 1 month 14 days ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2026 Déclaration du nombre de droits de vote et d'actions composant le capital d'une société, conformément à la réglementation en vigueur Droits De Vote Code De Commerce Actions AMF Société
BRIEF published on 01/27/2026 at 18:10, 2 months 10 days ago Approbation européenne pour l'utilisation d'Elucirem™ de Guerbet chez l'enfant dès la naissance Guerbet Commission Européenne Elucirem™ Imagerie Pédiatrique Contraste À Base De Gadolinium
BRIEF published on 01/27/2026 at 18:10, 2 months 10 days ago European Approval for Guerbet's Elucirem™ Use in Children from Birth European Commission Guerbet Elucirem™ Pediatric Imaging Gadolinium-Based Contrast
PRESS RELEASE published on 01/27/2026 at 18:05, 2 months 10 days ago New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission Guerbet's Elucirem (Gadopiclenol) receives European Commission approval for new indication in children from birth, with half-dose GBCA for MRI imaging European Commission Guerbet MRI Imaging Elucirem Gadopiclenol
BRIEF published on 12/19/2025 at 08:50, 3 months 19 days ago Guerbet nomme François Convenant à un poste de direction clé Comité Exécutif Guerbet Innovation Dans Le Secteur De La Santé François Convenant Radiologie Interventionnelle
Published on 04/07/2026 at 12:00, 3 minutes ago Banyan Gold Continues to Intersect High-Grade Gold in Powerline, AurMac Deposit, Yukon, Canada
Published on 04/07/2026 at 09:30, 2 hours 33 minutes ago Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
Published on 04/07/2026 at 09:05, 2 hours 58 minutes ago BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Published on 04/07/2026 at 09:01, 3 hours 2 minutes ago Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
Published on 04/07/2026 at 08:00, 4 hours 3 minutes ago Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
Published on 04/07/2026 at 11:50, 13 minutes ago 4finance announces early redemption of its EUR Notes due October 2026
Published on 04/07/2026 at 11:06, 56 minutes ago TenneT Germany completes inaugural ratings process and prepares for debt capital market debut
Published on 04/07/2026 at 10:58, 1 hour 5 minutes ago Original-Research: Daldrup & Söhne (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 10:05, 1 hour 58 minutes ago Ye celebrates his birthday on June 8 with a show at GelreDome; free bus transport arranged for fans from Germany
Published on 04/07/2026 at 12:00, 3 minutes ago Disclosure of shares outstanding and voting rights - 07.04.2026
Published on 04/07/2026 at 12:00, 3 minutes ago Déclaration nombre d'actions et droits de vote - 07.04.2026
Published on 04/07/2026 at 08:30, 3 hours 33 minutes ago Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:30, 3 hours 33 minutes ago Edenred obtient la note « A » au CDP et rejoint les leaders mondiaux engagés pour le climat
Published on 04/07/2026 at 08:00, 4 hours 3 minutes ago Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
